platelet and coagulation disorders I & II - Zaloga Flashcards
what is the most common cause of mild bleeding diathesis?
-von willebrand disease and aspirin use
hemophilias
-clotting factors aren’t working –> severe, deeper bleeding
defects of small vessels
- present with purpura (hemorrhage into skin) or ecchymoses (bruises)
- hematoma is extravasated blood that creates a mass
defects of primary hemostasis (platelet plug)
- due to platelets or von willebrand disease
- present with small bleeds in skin or mucosa –> petechia, epistaxis, GI, menorrhagia
defects of secondary hemostasis (coagulation)
- bleeds into soft tissues (muscles/joints)
- hemarthrosis (bleeding into joints)
cardiovascular collapse and shock if mechanisms cannot keep up with blood loss –> organ failure
lab tests for evaluating hemorrhagic diathesis
- prolonged PT or PTT
- platelet counts
- tests for platelet function: aggregate in response to thrombin
bleeding disorder from vessel wall abnormalities
- often have petechia and purpura
- platelet count, PT, PTT normal (only vessel wall is dysfunctional)
cause:
1. infections causing vasculitis; DIC
2. drug rxns leading to hypersensitivity of vessels
3. scurvy and Ehlers-danlos –> collagen defects
4. Henoch-Schönlein purpura –> activate compliment causing vessel damage
5. Perivascular amyloidosis –> build up of amyloid light chain within plasma
6. Hereditary hemorrhagic telangiectasia (aka Weber-Osler-Rendu syndrome) –> dilated, tortuous vessels leading to severe bleeding
bleeding disorders from platelet # - thrombocytopenia
-quantitative effects
- <100,000 is thrombocytpenia
- worry about spontaneous nontraumatic intracranial bleeding when platelet count <20,000; bleeding also in skin (petechia) and mucous membranes (GI;GU)
- normal PT/PTT
causes of thrombocytopenia:
- decreased platelet production (ex. marrow suppression, MDS)
- decreased platelet survival (ex. ITP, alloantibodies, DIC, thrombotic microangiopathies)
- sequestration: splenomegaly
- dilution: massive transfusions
bleeding disorders due to platelet dysfunctions
-qualitative effects
-inherited or acquired –> normal platelet count, but not function
inherited disorders:
- Bernard-Soulier Syndrome: deficiency of GP1b-9 –> defective adhesion of platelets
- Glanzmann Thrombasthenia: deficiency of GP2b/3a –> defective platelet aggregation (cannot bind fibrinogen in response to ADP)
- disorders of platelet secretion (storage pool disorder): mediators not released from granules during platelet activation (do not recruit other platelets)
acquired disorders:
- aspirin and NSAIDs: inhibits COX which makes TXA2 for platelet aggregation
- uremia: defects in adhesion, aggregation, and granule secretion
immune thrombocytopenic purpura
- IgG against the platelet antigens (GP2b/3a or GP1b-9)**
- adults: due to autoimmune (SLE) or lymphocyte abnormality, chronic ITP, has viral prodrome
- child: develop acute ITP that trigger autoantibodies and is usually viral
- thrombocytopenia improved with splenectomy (not producing antibodies)
- primary ITP –> no symptoms, only petechia and purpura
- chronic ITP –> thrombocytopenia, low platelets, increased megakaryocytes (need to make more thrombocytes so it makes immature cells), normal PT/PTT
microangiopathic hemolytic anemia (MAHA)
- excessive activation of platelets leads to coagulation in small vessels –> schistocytes***
- see in TTP and HUS**
thrombotic thrombocytopenic purpura (TTP)
- decreased ADAMTS13 enzyme –> cannot degrade vWF into monomers –> abnormal platelet adhesion/aggregation forming micro thrombi –> organ dysfunction
- leads to thrombocytopenia (platelets used up) and MAHA (schistocytes)
- due to autoantibody (inhibits metalloprotease) or inherited mutation
- pentad of fever, kidney problems, NEURO defects***
hemolytic uremic syndrome (HUS)
- infection of E. coli 0157:H7 –> release verotoxin (shiga like toxin) –> damage endothelial cells and activate platelets –> producing micro thrombi –> organ dysfunction
- normal levels of ADAMTS13
- bloody diarrhea and irreversible RENAL damage**
- no CNS symptoms
- see MAHA and thrombocytopenia
atypical HUS: defects in compliment regulatory proteins (ex. factor H, CD46, factor I) –> platelets susceptible to compliment activation –> thrombocytopenia**
-due to inherited mutations or acquired autoantibodies
DIC and thrombotic microangiopathies**
- similarities: microvascular occlusion and MAHA
- differences: no coagulation cascade activation in HUS or TTP (PT and PTT normal)**, but there is activation in DIC
drug induced thrombocytopenia
- decreases platelet count
- heparin forms complex with platelet factor 4 (PF4) on the surface of platelets –> IgG autoantibodies against complex bind to platelet Fc receptor (opsonized) –> consumed by macrophages in spleen –> thrombocytopenia
- platelet fragments in circulation –> activate remaining platelets –> thrombosis (dangerous)
- main drug used is heparin - HIT***
other drugs: quinine, quinidine, vancomycin bind platelet GPs creating antigenic determinants recognized by antibodies
